Distinct ErbB-2 coupled signaling pathways promote mammary tumors with unique pathologic and transcriptional profiles

Babette Schade1, Sonya H L Lam, Daniela Cernea

  • 1Molecular Oncology Group, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.

Cancer Research
|August 19, 2007
PubMed

Insights

Different ErbB-2 signaling pathways impact breast cancer progression. The Neu-YB pathway drives aggressive, metastatic tumors with unique gene expression, unlike other ErbB-2 sites.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • ErbB-2 (Human Epidermal growth factor Receptor 2) overexpression is common in breast cancer, linked to poor prognosis.
  • Specific tyrosine-autophosphorylation sites in ErbB-2's cytoplasmic tail recruit different adaptor proteins and mediate transforming signals.
  • Previous studies identified growth factor receptor binding protein 2 (Grb2; Neu-YB) and Src homology and collagen (Shc; Neu-YD) binding sites as inducers of mammary tumorigenesis and metastasis.

Purpose of the Study:

  • To investigate the role of the remaining two ErbB-2 autophosphorylation sites (Neu-YC and Neu-YE) in mammary tumor development.
  • To compare the biological and transcriptional profiles of mouse models with different ErbB-2 autophosphorylation site mutations.

Main Methods:

  • Generation of transgenic mouse models expressing specific ErbB-2 autophosphorylation site mutants (Neu-YC, Neu-YE, Neu-YB).
  • Pathological and transcriptional analysis of mammary tumors developed in these mouse models.
  • Comparison of gene expression profiles, focusing on genes associated with tumor progression.

Main Results:

  • Transgenic mice with Neu-YC and Neu-YE sites developed metastatic mammary tumors with shared pathological and transcriptional features.
  • The Neu-YB mouse model exhibited unique pathology and high metastatic potential, associated with a distinct transcriptional profile.
  • Upregulated genes in Neu-YB tumors included metalloproteinases and chemokines, promoting malignant progression.
  • Neu-YB tumor cells showed high intracellular levels of chemokine CXCL12/SDF-1alpha, suggesting aggressive behavior.

Conclusions:

  • Distinct ErbB-2 autophosphorylation sites activate different signaling pathways.
  • These distinct pathways significantly influence the biological behavior and metastatic potential of ErbB-2-induced mammary tumors.
  • The Neu-YB pathway is particularly linked to aggressive tumor progression and metastasis in breast cancer models.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...